I want to ask about the project. How do you tackle industry-sponsored clinical trials, as you know all of them are manipulated to fit the customer?
Mainly, Orvium is looking to be eliminating market inefficiencies and improve the quality and effectiveness of scientific publishing that is in the current outdated model, Orvium is looking to be the leading platform for the research community which will give the benefits back to the community so that everyone involved will benefit more.
The team hasn't specifically mentioned this collusion that you are talking about with regards to clinical trials, however, you can see that the team plans on building a lot of governance within the platform, for example, there will be a reputation based voting power which will determine the reputation of individual contributors.
So hopefully, the more freedom of contributors will stop this issue you are talking about by other trials results being posted with great reviews, for instance, seems like this would be the future and hopefully the downfall of the current publishing methods in my opinion.
You can read more on the full Community driven journals and governance rules from page 23 of the whitepaper:
https://orvium.docsend.com/view/nvr6ywj